Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Graeber

Showing results (121-130 of 158) with videos related to

Pageof 16
Sort By:
Cell Reports|December 12, 2019
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 ExpressionAngel Garcia-Diaz, Daniel Sanghoon Shin, Blanca Homet Moreno, et al.
Journal of Medicinal Chemistry|February 9, 2026
Discovery and Optimization of Orally Bioavailable Heterobifunctional Degraders of KAT2A/B for the Treatment of CancerJames Neef, Kimberly S Straley, Chinmoy Mukherjee, et al.
NPJ Precision Oncology|July 9, 2020
Somatic copy number profiling from hepatocellular carcinoma circulating tumor cellsColin M Court, Shuang Hou, Lian Liu, et al.
Nature|February 18, 2026
Author Correction: BCL6 enables Ph<sup>+</sup> acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibitionCihangir Duy, Christian Hurtz, Seyedmehdi Shojaee, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2024
PGC-1α drives small cell neuroendocrine cancer progression toward an ASCL1-expressing subtype with increased mitochondrial capacityGrigor Varuzhanyan, Chia-Chun Chen, Jack Freeland, et al.
Nature|May 20, 2011
BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibitionCihangir Duy, Christian Hurtz, Seyedmehdi Shojaee, et al.
Nature Communications|November 21, 2024
Integrated molecular and functional characterization of the intrinsic apoptotic machinery identifies therapeutic vulnerabilities in gliomaElizabeth G Fernandez, Wilson X Mai, Kai Song, et al.
Cancer Research|June 8, 2011
18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancersNicolaos Palaskas, Steven M Larson, Nikolaus Schultz, et al.
Science (New York, N.Y.)|March 2, 2013
Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responsesRosane M B Teles, Thomas G Graeber, Stephan R Krutzik, et al.
Journal for Immunotherapy of Cancer|December 21, 2025
Clinical and molecular characterization of <i>AXL</i> in colorectal cancer, CALGB (Alliance)/SWOG 80405 and real-world dataKaram Ashouri, Joshua Millstein, Yan Yang, et al.
Pageof 16

Showing results (121-130 of 158) with videos related to

Sort By:
Pageof 16
Cell Reports|December 12, 2019
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 ExpressionAngel Garcia-Diaz, Daniel Sanghoon Shin, Blanca Homet Moreno, et al.
Journal of Medicinal Chemistry|February 9, 2026
Discovery and Optimization of Orally Bioavailable Heterobifunctional Degraders of KAT2A/B for the Treatment of CancerJames Neef, Kimberly S Straley, Chinmoy Mukherjee, et al.
NPJ Precision Oncology|July 9, 2020
Somatic copy number profiling from hepatocellular carcinoma circulating tumor cellsColin M Court, Shuang Hou, Lian Liu, et al.
Nature|February 18, 2026
Author Correction: BCL6 enables Ph<sup>+</sup> acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibitionCihangir Duy, Christian Hurtz, Seyedmehdi Shojaee, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2024
PGC-1α drives small cell neuroendocrine cancer progression toward an ASCL1-expressing subtype with increased mitochondrial capacityGrigor Varuzhanyan, Chia-Chun Chen, Jack Freeland, et al.
Nature|May 20, 2011
BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibitionCihangir Duy, Christian Hurtz, Seyedmehdi Shojaee, et al.
Nature Communications|November 21, 2024
Integrated molecular and functional characterization of the intrinsic apoptotic machinery identifies therapeutic vulnerabilities in gliomaElizabeth G Fernandez, Wilson X Mai, Kai Song, et al.
Cancer Research|June 8, 2011
18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancersNicolaos Palaskas, Steven M Larson, Nikolaus Schultz, et al.
Science (New York, N.Y.)|March 2, 2013
Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responsesRosane M B Teles, Thomas G Graeber, Stephan R Krutzik, et al.
Journal for Immunotherapy of Cancer|December 21, 2025
Clinical and molecular characterization of <i>AXL</i> in colorectal cancer, CALGB (Alliance)/SWOG 80405 and real-world dataKaram Ashouri, Joshua Millstein, Yan Yang, et al.
Pageof 16